The Clinical Profile of Benralizumab in the Management of Severe Eosinophilic Asthma

Therapeutic Advances in Respiratory Disease - United Kingdom
doi 10.1177/1753465816667659
Full Text
Abstract

Available in full text

Date
Authors
Publisher

SAGE Publications

Related search

Benralizumab for the Treatment of Severe Eosinophilic Asthma

Prescriber
Pharmacology
2018English

Relationship Between Benralizumab Exposure and Efficacy for Patients With Severe Eosinophilic Asthma

Clinical Pharmacology and Therapeutics
Pharmacology
2019English

Benralizumab Efficacy for Patients With Fixed Airflow Obstruction and Severe, Uncontrolled Eosinophilic Asthma

Annals of Allergy, Asthma and Immunology
Respiratory MedicinePulmonaryAllergyImmunology
2020English

Efficacy and Safety of Treatment With Biologicals (Benralizumab, Dupilumab, Mepolizumab, Omalizumab and Reslizumab) for Severe Eosinophilic Asthma

Allergy: European Journal of Allergy and Clinical Immunology
AllergyImmunology
2020English

Daily Patient-Reported Health Status Assessment Improvements With Benralizumab for Patients With Severe, Uncontrolled Eosinophilic Asthma

Journal of Asthma and Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2019English

Ability of Serum IgE Concentration to Predict Exacerbation Risk and Benralizumab Efficacy for Patients With Severe Eosinophilic Asthma

Advances in Therapy
MedicinePharmacology
2019English

Benralizumab in the Treatment of Severe Asthma: Design, Development and Potential Place in Therapy

Drug Design, Development and Therapy
Drug DiscoveryPharmacologyPharmaceutical Science
2018English

Benralizumab: A Unique IL-5 Inhibitor for Severe Asthma

Journal of Asthma and Allergy
ImmunologyPulmonaryAllergyRespiratory Medicine
2016English

Benralizumab, an Add-On Treatment for Severe Eosinophilic Asthma: Evaluation of Exacerbations, Emergency Department Visits, Lung Function, and Oral Corticosteroid Use

Therapeutics and Clinical Risk Management
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy